(E)-2-(3-(3'-Methyl-[1,1'-biphenyl]-4-yl)acrylamido)benzoic Acid

ID: ALA4858223

PubChem CID: 164611968

Max Phase: Preclinical

Molecular Formula: C23H19NO3

Molecular Weight: 357.41

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2ccc(/C=C/C(=O)Nc3ccccc3C(=O)O)cc2)c1

Standard InChI:  InChI=1S/C23H19NO3/c1-16-5-4-6-19(15-16)18-12-9-17(10-13-18)11-14-22(25)24-21-8-3-2-7-20(21)23(26)27/h2-15H,1H3,(H,24,25)(H,26,27)/b14-11+

Standard InChI Key:  LDMUEATZALOQES-SDNWHVSQSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   31.1899  -18.0956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1887  -18.9230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9035  -19.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6200  -18.9225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6171  -18.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9017  -17.6829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3300  -17.6768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0461  -18.0866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7589  -17.6714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4750  -18.0811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.1878  -17.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7558  -16.8464    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.8998  -18.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6123  -17.6631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6095  -16.8372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8885  -16.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1790  -16.8444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9009  -18.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1871  -19.3160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.6160  -19.3141    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4758  -19.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7615  -18.9204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0471  -19.3317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0460  -20.1575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7652  -20.5704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4765  -20.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7674  -21.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  2  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 13 18  1  0
 18 19  1  0
 18 20  2  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  2 21  1  0
 25 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4858223

    ---

Associated Targets(Human)

TRPM2 Tchem Transient receptor potential cation channel subfamily M member 2 (348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 357.41Molecular Weight (Monoisotopic): 357.1365AlogP: 5.01#Rotatable Bonds: 5
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.55CX Basic pKa: CX LogP: 6.04CX LogD: 2.68
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.63Np Likeness Score: -0.72

References

1. Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L..  (2021)  The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo.,  64  (7.0): [PMID:33784097] [10.1021/acs.jmedchem.0c02129]

Source